THE ENANTIOMERS OF THE VALPROIC ACID ANALOG 2-NORMAL-PROPYL-4-PENTYNOIC ACID (4-YN-VPA) - ASYMMETRIC-SYNTHESIS AND HIGHLY STEREOSELECTIVE TERATOGENICITY IN MICE

被引:30
作者
HAUCK, RS [1 ]
NAU, H [1 ]
机构
[1] FREE UNIV BERLIN,INST TOXICOL & EMBRYOPHARMACOL,GARYSTR 5,W-1000 BERLIN 33,GERMANY
关键词
R(+)-AND S(-)-2-NORMAL-PROPYL-4-PENTYNOIC ACID; ASYMMETRIC SYNTHESIS; ENANTIOSELECTIVE TERATOGENICITY; VALPROIC ACID;
D O I
10.1023/A:1015832411981
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
The teratogenic activities of R(+)- and S(-)-2-n-propyl-4-pentynoic acid (R and S-4-yn-VPA), the enantiomers of the highly teratogenic valproic acid (VPA) analogues (+/-)-4-yn-VPA, were investigated in mice. The enantiomers were prepared via asymmetric synthesis, each in three steps employing the chiral auxiliaries (4R,5S)-4-methyl-5-phenyl-2-oxazolidinone and S-4-benzyl-2-oxazolidinone. The determination of the absolute configurations and the optical purities is described. R(+)4-yn-VPA contained 7%, and S(-)-4-yn-VPA 8%/, of the respective antipodes. The aqueous solutions of the sodium salts of R- and S-4-yn-VPA were administered as single i.p. injections during early organogenesis in the mouse (day 8 of gestation) using the induction of exencephaly as the teratological end point. Dose/exencephaly curves indicated that S4-yn-VPA is 7.5 times more teratogenic than its antipode, 1.9 times more teratogenic than (+/-)-4-yn-VPA and 3.9 times more teratogenic than the parent drug VPA. In contrast, the neurotoxicity (maternal toxicity) of the 4-yn-VPA enantiomers was found to be independent of the stereochemical configuration and lower than achieved after VPA administration. Due to its low neurotoxicity and highly stereoselective neural tube-inducing activity, S-4-yn-VPA should prove an important tool for the investigation of molecular mechanism of the teratogenic action in this class of compounds; R-4-yn-VPA could act as the negative control in these studies.
引用
收藏
页码:850 / 855
页数:6
相关论文
共 32 条
[11]  
HAUCK RS, 1990, TERATOLOGY, V41, P663
[12]   FETAL GROWTH, MAJOR MALFORMATIONS, AND MINOR ANOMALIES IN INFANTS BORN TO WOMEN RECEIVING VALPROIC ACID [J].
JAGERROMAN, E ;
DEICHL, A ;
JAKOB, S ;
HARTMANN, AM ;
KOCH, S ;
RATING, D ;
STELDINGER, R ;
NAU, H ;
HELGE, H .
JOURNAL OF PEDIATRICS, 1986, 108 (06) :997-1004
[13]  
KAO J, 1981, Teratogenesis Carcinogenesis and Mutagenesis, V1, P367, DOI 10.1002/tcm.1770010405
[14]   POSSIBLE TERATOGENIC EFFECT OF VALPROATE DURING PREGNANCY [J].
KOCH, S ;
JAGERROMAN, E ;
RATING, D ;
HELGE, H .
JOURNAL OF PEDIATRICS, 1983, 103 (06) :1007-1008
[15]  
LICHTFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
[16]  
LINDHOUT D, 1984, LANCET, V2, P396
[17]  
LINDHOUT D, 1986, LANCET, V1, P1392
[18]   A NEW MODEL FOR EMBRYOTOXICITY TESTING - TERATOGENICITY AND PHARMACOKINETICS OF VALPROIC ACID FOLLOWING CONSTANT-RATE ADMINISTRATION IN THE MOUSE USING HUMAN THERAPEUTIC DRUG AND METABOLITE CONCENTRATIONS [J].
NAU, H ;
ZIERER, R ;
SPIELMANN, H ;
NEUBERT, D ;
GANSAU, C .
LIFE SCIENCES, 1981, 29 (26) :2803-2813
[19]  
NAU H, 1981, J PHARMACOL EXP THER, V219, P768
[20]   VALPROIC ACID-INDUCED NEURAL-TUBE DEFECTS IN MOUSE AND HUMAN - ASPECTS OF CHIRALITY, ALTERNATIVE DRUG DEVELOPMENT, PHARMACOKINETICS AND POSSIBLE MECHANISMS [J].
NAU, H ;
HAUCK, RS ;
EHLERS, K .
PHARMACOLOGY & TOXICOLOGY, 1991, 69 (05) :310-321